J&J uses web video, teacher outreach in UK ADHD effort

Share this article:
J&J uses web video, teacher outreach in UK ADHD effort
J&J uses web video, teacher outreach in UK ADHD effort

Johnson & Johnson's Janssen-Cilag launched an animated patient education video aimed at showing viewers the world from the perspective of a child with ADHD and urging parents to see a doctor about behavioral problems.

The film is part of an unbranded UK campaign including outreach to teachers and is featured on Livingwithadhd.co.uk. The film employs a technique called “rotoscoping,” in which real actors are filmed and converted into animations, and was developed through interviews with patients, parents, doctors and teachers. It visually depicts the child's attention drifting and explores the guilt that parents of children with ADHD often feel.

It's meant encourage parents to take the initial step of seeing a doctor about their child's behavioral problems – a step that research shows gives parents great satisfaction, the company said, either for relief that a diagnosis has been made or for reassurance at having spoken to a professional.

“It might be that certain teachers currently have children with ADHD in their classrooms but that haven't yet realized it or are struggling to cope,” said ADHD educational advisor Holly Evans in a release. “If improved understanding and knowledge about ADHD can filter down to at least a small proporation of the teaching population, it will make a big impact.”

The J&J unit makes Concerta XL for ADHD.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...